Literature DB >> 18060800

Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues.

Hideaki Takagi1, Naomichi Furuya, Naoya Kojima.   

Abstract

The present study demonstrates that liposomes coated with synthesized neoglycolipids constructed from mannotriose and dipalmitoylphosphatidylethanolamine (Man3-DPPE) activate peritoneal macrophages (PEMs) to up-regulate expression of co-stimulatory molecules and preferentially secrete IL-12. Injection of Man3-DPPE-coated liposomes (oligomannose-coated liposome, OMLs) into the peritoneal cavity of mice resulted in specific and rapid incorporation of OMLs into PEMs. Upon OML incorporation, expression of co-stimulatory molecules, CD40, CD80, and CD86, and of MHC class II molecules was clearly enhanced on PEMs. In addition, production of IL-12 from PEMs was clearly promoted in response to OML incorporation, while those of IL-1 and IL-6 were suppressed. In contrast, liposomes coated with other carbohydrates and those without a carbohydrate-coating did not induce production of these cytokines. The cytokine profile produced from PEMs in response to OML clearly differed from those in response to ligands for TLRs, in which productions of IL-1 and/or IL-6 were strongly enhanced. Taken together, the results indicate that OMLs activate PEMs through a particular type of signal pathway distinct from those activated with TLR ligands, leading to specific production of IL-12 and consequent maturation of PEMs. Thus, OMLs can be used as a novel adjuvant for efficient activation of specific cellular immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060800     DOI: 10.1016/j.cyto.2007.10.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

Review 1.  Next generation immunotherapy for tree pollen allergies.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Pathogen-derived oligosaccharides improve innate immune response to intracellular parasite infection.

Authors:  Alex Osanya; Eun-Ho Song; Kyle Metz; Raeann M Shimak; Paola Mercedes Boggiatto; Elise Huffman; Charles Johnson; Jesse M Hostetter; Nicola L B Pohl; Christine A Petersen
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

3.  SIGNR1 ligation on murine peritoneal macrophages induces IL-12 production through NFkappaB activation.

Authors:  Chiaki Kato; Naoya Kojima
Journal:  Glycoconj J       Date:  2010-06-30       Impact factor: 2.916

4.  In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose.

Authors:  Yuko Matsuoka; Yoko Kawauchi; Kiyotaka Kawauchi; Akari Takiyama; Shohei Kojima; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2019-04-23       Impact factor: 2.916

5.  Synthesis of multivalent tuberculosis and Leishmania-associated capping carbohydrates reveals structure-dependent responses allowing immune evasion.

Authors:  Eun-Ho Song; Alex O Osanya; Christine A Petersen; Nicola L B Pohl
Journal:  J Am Chem Soc       Date:  2010-08-25       Impact factor: 15.419

6.  Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.

Authors:  Mariko Ishii; Naoya Kojima
Journal:  Glycoconj J       Date:  2009-10-09       Impact factor: 2.916

7.  Liposomes and nanotechnology in drug development: focus on oncotargets.

Authors:  Tomohiro Kozako; Naomichi Arima; Makoto Yoshimitsu; Shin-Ichro Honda; Shinji Soeda
Journal:  Int J Nanomedicine       Date:  2012-09-14

8.  Wall teichoic acid-dependent phagocytosis of intact cell walls of Lactiplantibacillus plantarum elicits IL-12 secretion from macrophages.

Authors:  Naoya Kojima; Shohei Kojima; Shin Hosokawa; Yoshiki Oda; Daisuke Zenke; Yuta Toura; Emi Onohara; Shin-Ichi Yokota; Masato Nagaoka; Yasuhiro Kuroda
Journal:  Front Microbiol       Date:  2022-08-09       Impact factor: 6.064

Review 9.  Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.

Authors:  Naoya Kojima; Mariko Ishii; Yoko Kawauchi; Hideaki Takagi
Journal:  Biomed Res Int       Date:  2013-10-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.